Loading...
Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway.
Haake, Kathrin Neehus, Anna-Lena Buchegger, Theresa Kühnel, Mark Philipp Blank, Patrick Philipp, Friederike Oleaga-Quintas, Carmen Schulz, Ansgar Grimley, Michael Goethe, Ralph
Haake, Kathrin
Neehus, Anna-Lena
Buchegger, Theresa
Kühnel, Mark Philipp
Blank, Patrick
Philipp, Friederike
Oleaga-Quintas, Carmen
Schulz, Ansgar
Grimley, Michael
Goethe, Ralph
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-02-19
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 6.53 MB
Other Titles
Abstract
nterferon γ (IFN-γ) was shown to be a macrophage activating factor already in 1984. Consistently, inborn errors of IFN-γ immunity underlie Mendelian Susceptibility to Mycobacterial Disease (MSMD). MSMD is characterized by genetic predisposition to disease caused by weakly virulent mycobacterial species. Paradoxically, macrophages from patients with MSMD were little tested. Here, we report a disease modeling platform for studying IFN-γ related pathologies using macrophages derived from patient specific induced pluripotent stem cells (iPSCs). We used iPSCs from patients with autosomal recessive complete- and partial IFN-γR2 deficiency, partial IFN-γR1 deficiency and complete STAT1 deficiency. Macrophages from all patient iPSCs showed normal morphology and IFN-γ-independent functionality like phagocytic uptake of bioparticles and internalization of cytokines. For the IFN-γ-dependent functionalities, we observed that the deficiencies played out at various stages of the IFN-γ pathway, with the complete IFN-γR2 and complete STAT1 deficient cells showing the most severe phenotypes, in terms of upregulation of surface markers and induction of downstream targets. Although iPSC-derived macrophages with partial IFN-γR1 and IFN-γR2 deficiency still showed residual induction of downstream targets, they did not reduce the mycobacterial growth when challenged with Bacillus Calmette-Guérin. Taken together, we report a disease modeling platform to study the role of macrophages in patients with inborn errors of IFN-γ immunity.
Citation
Cells. 2020 Feb 19;9(2). pii: cells9020483. doi: 10.3390/cells9020483.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
2073-4409
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International